NO20084478L - Konjugerte lipidderivater - Google Patents

Konjugerte lipidderivater

Info

Publication number
NO20084478L
NO20084478L NO20084478A NO20084478A NO20084478L NO 20084478 L NO20084478 L NO 20084478L NO 20084478 A NO20084478 A NO 20084478A NO 20084478 A NO20084478 A NO 20084478A NO 20084478 L NO20084478 L NO 20084478L
Authority
NO
Norway
Prior art keywords
lipid derivatives
conjugated lipid
compounds
unsaturated fatty
compositions
Prior art date
Application number
NO20084478A
Other languages
English (en)
Inventor
Anne Kristin Holmeide
Original Assignee
Pronova Biopharma Norge As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronova Biopharma Norge As filed Critical Pronova Biopharma Norge As
Publication of NO20084478L publication Critical patent/NO20084478L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Abstract

Den foreliggende oppfinnelsen vedrører nye a,ß-umettede fettsyrederivater av umettede fettsyrer, fremgangsmåter for fremstilling av slike forbindelser, farmasøytiske blandinger og lipidpreparater som inneholder slike forbindelser og anvendelse av slike forbindelser og preparater innenfor medisin.
NO20084478A 2006-03-23 2008-10-23 Konjugerte lipidderivater NO20084478L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0605900.0A GB0605900D0 (en) 2006-03-23 2006-03-23 Modulators of nuclear receptors
PCT/IB2007/000731 WO2007107869A2 (en) 2006-03-23 2007-03-23 Lipid derivatives

Publications (1)

Publication Number Publication Date
NO20084478L true NO20084478L (no) 2008-10-23

Family

ID=36384087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084478A NO20084478L (no) 2006-03-23 2008-10-23 Konjugerte lipidderivater

Country Status (12)

Country Link
US (2) US8178708B2 (no)
EP (1) EP2007702A2 (no)
JP (1) JP2009530366A (no)
KR (1) KR20080105095A (no)
CN (1) CN101410362B (no)
BR (1) BRPI0708981A2 (no)
CA (1) CA2647020A1 (no)
GB (1) GB0605900D0 (no)
MX (1) MX2008012089A (no)
NO (1) NO20084478L (no)
RU (1) RU2480447C2 (no)
WO (1) WO2007107869A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090203778A1 (en) 2005-05-04 2009-08-13 Morten Bryhn Fatty acid analogues, i.e. including dha derivatives for uses as a medicament
GB0605900D0 (en) 2006-03-23 2006-05-03 Lipigen As Modulators of nuclear receptors
CN101535238A (zh) 2006-11-01 2009-09-16 普罗诺瓦生物医药挪威公司 作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质
WO2008132552A2 (en) * 2006-11-01 2008-11-06 Pronova Biopharma Norge As Omega-3 lipid compounds
DE102007051339A1 (de) * 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
WO2009134147A1 (en) * 2008-05-02 2009-11-05 Pronova Biopharma Norge As Lipid compositions containing derivatives of epa and dha an their use thereof
WO2009149496A1 (en) * 2008-06-10 2009-12-17 Central Northern Adelaide Health Service Treatment of diabetes and complications thereof and related disorders
KR101898610B1 (ko) 2010-08-31 2018-09-14 서울대학교산학협력단 ＰＰＡＲδ 활성물질의 태자 재프로그래밍 용도
DK2817287T3 (da) * 2012-02-24 2019-01-02 Arbutus Biopharma Corp Trialkyl kationisk lipid og metoder til anvendelse deraf

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL296925A (no) * 1900-01-01
DE178298C (no)
DE178287C (no) *
GB549933A (en) * 1940-07-11 1942-12-15 Hoffmann La Roche Process for the manufacture of í¸-phytadienic acid
US4264517A (en) * 1978-12-11 1981-04-28 G.D. Searle & Co. Alkylphenyl 5Z,8Z,11Z,14Z,17Z-eicosapentaenoates
GB2218904A (en) * 1988-05-27 1989-11-29 Renafield Limited Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid
US5407816A (en) * 1992-02-20 1995-04-18 Phyton Catalytic, Inc. Enhanced production of taxol and taxanes by cell cultures of taxus species
JP2001509165A (ja) * 1997-01-24 2001-07-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア バリヤ機能の回復、表皮の分化の促進及び増殖の抑制のためのＦＸＲ、ＰＰＡＲα及びＬＸＲαの活性剤の使用
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
US6586461B1 (en) * 1998-06-16 2003-07-01 Wayne State University Prenyl transferase inhibitors
EP1204413A2 (en) * 1999-07-23 2002-05-15 Bioparken AS Control of crustacean infestation of aquatic animals
ITMI20020960A1 (it) 2002-05-07 2003-11-07 Univ Degli Studi Milano Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
US7981915B2 (en) * 2003-04-30 2011-07-19 Beth Israel Deaconess Medical Center Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
DE10322635A1 (de) * 2003-05-20 2004-12-23 Symrise Gmbh & Co. Kg Verwendung von alpha-Terpenen als Riechstoffe
GB0605900D0 (en) 2006-03-23 2006-05-03 Lipigen As Modulators of nuclear receptors

Also Published As

Publication number Publication date
WO2007107869A2 (en) 2007-09-27
US8178708B2 (en) 2012-05-15
CA2647020A1 (en) 2007-09-27
US20120232143A1 (en) 2012-09-13
CN101410362B (zh) 2013-07-10
JP2009530366A (ja) 2009-08-27
RU2008141907A (ru) 2010-04-27
RU2480447C2 (ru) 2013-04-27
CN101410362A (zh) 2009-04-15
MX2008012089A (es) 2008-10-07
BRPI0708981A2 (pt) 2011-06-21
EP2007702A2 (en) 2008-12-31
KR20080105095A (ko) 2008-12-03
US20090105499A1 (en) 2009-04-23
GB0605900D0 (en) 2006-05-03
WO2007107869A3 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
NO20084478L (no) Konjugerte lipidderivater
MX2011012122A (es) Derivados de tiofeno.
UY30438A1 (es) Derivados n-sustituidos de 5-halo-4-[2-alquil-1-sustituidos-1h-imidazol-5-il]pirimidin-2-amina, composiciones-procesos para su preparacion y usos
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
ECSP088414A (es) Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria
DOP2011000264A (es) Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
UY31046A1 (es) Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
UA94395C2 (ru) Производное изоксазолина и способ его получения
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
EA201490653A1 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
ATE485261T1 (de) Salicylsäurederivate
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
BRPI0408848B8 (pt) composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
MX2009012713A (es) Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
ATE454889T1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
MX2009012841A (es) Nuevos derivados del acido 3-fenil propanoico que son activadores de los receptores del tipo del receptor activado por el proliferador de peroxisoma, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
CY1107277T1 (el) Βενζισοξαζολες
EA200870567A1 (ru) Производные 2-алкокси-3,4,5-тригидроксиалкиламида, их получение, композиции, их содержащие, и применение
UY29550A1 (es) Derivados de (sulfamoil-alquil)-amida de ácido heteroaril-carboxílico como inhibidores del factor xa
WO2007039821A3 (en) Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application